Meningitis Literature

Balada-Llasat JM, Rosenthal N, Hasbun R, et al. Cost of managing meningitis and encephalitis among adult patients in the United States. Int J Infect Dis 2018 (published online Apr 24)

Beeslaar J, Absalon J, Balmer P, et al. Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults. Vaccine 2018 (published online Jun 1)

Bennett D, O'Lorcain P, Morgan S, et al. Epidemiology of two decades of invasive meningococcal disease in the Republic of Ireland: an analysis of national surveillance data on laboratory-confirmed cases from 1996 to 2016. Epidemiol Infect 2019 (published online Mar 12)

Bozio CH, Blain A, MacNeil J, et al. Meningococcal disease surveillance in men who have sex with men—United States, 2015–2016. MMWR 2018 Sep 28;67(38):1060-3

Bozio CH, Vuong J, Dokubo EK, et al. Outbreak of Neisseria meningitides serogroup C outside the meningitis belt—Liberia, 2017: an epidemiological and laboratory investigation. Lancet Infect Dis 2018 (published online Oct 15)

Chu V, Carpenter DM, Winter K, et al. Increased risk of late-onset Streptococcus pneumoniae meningitis in adults with prior head or spine surgeries. Clin Infect Dis 2018 (published online Nov 19)

Davizon ES, Soeters HM, Miller L, et al. Two cases of meningococcal disease in one family separated by an extended period — Colorado, 2015-2016. MMWR 2018 Mar 30;67(12):366-8

Dbaibo G, Favila JCT, Traskine M, et al. Immunogenicity and safety of MenACWY-TT, a meningococcal conjugate vaccine, co-administered with routine childhood vaccine in healthy infants: a phase III, randomized study. Vaccine 2018 (published online May 18)

De Serres G, Billard MN, Gariepy MC, et al. Short-term safety of 4CMenB vaccine during a mass meningococcal B vaccination campaign in Quebec, Canada. Vaccine 2018 (published online Nov 19)

Findlow H, Campbell H, Lucidarme J, et al. Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16. Euro Surveill 2019 Jan 3;24(1):pii=1700818

Frank T, Hong E, Mbecko JR, et al. Emergence of Neisseria meningitidis serogroup W, Central African Republic. Emerg Infect Dis 2018 Nov;24(11)

Guiddir T, Gros M, Hong E, et al. Unusual initial abdominal presentations of invasive meningococcal disease. Clin Infect Dis 2018 (published online Mar 28)

Guo LU, Li YJ, Liu LL, et al. Detection of pediatric bacterial meningitis pathogens from cerebrospinal fluid by next-generation sequencing technology. J Infection 2018 (published online Dec 11)

Hasbun R, Wootton SH, Rosenthal N, et al. Epidemiology of meningitis and encephalitis in infancts and children in the United States, 2011-2014. Pediatr Infect Dis J 2019 Jan;38(1):37-41

Hassan A, Mustapha GU, Lawal BB, et al. Time delays in the response to the Neisseria meningitides serogroup C outbreak in Nigeria – 2017. PLoS One 2018 Jun 19;13(6):e0199257

Hitchings MDT, Coldiron ME, Grais RF, et al. Analysis of a meningococcal meningitis outbreak in Niger — potential effectiveness of reactive prophylaxis. PLOS Negl Trop Dis 019 Mar 11;13(3):e0007077

Kempe A, Allison MA, MacNeil JR, et al. Adoption of serogroup B meningococcal vaccine recommendations. Pediatrics 2018 (published online Aug 20)

Knol MJ, Ruijs WLM, Antonise-Kamp L, et al. Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018. Euro Surveill 2018 Apr 19;23(16):pii=18-00158

Leeds IL, Namasivayam V, Bamogo A, et al. Cost effectiveness of meningococcal serogroup B vaccination in college-aged young adults. Am J Prevent Med 2018 (published online Dec 17)

Mbaeyi SA, Joseph SJ, Blain A, et al. Meningococcal disease among college-aged young adults: 2014-2016. Pediatrics 2019 (published online Jan 1)

McGill F, Griffiths MJ, Bonnett LJ, et al. Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study. Lancet Infect Dis 2018 (published online Jun 2018)

Meiring S, Cohen C, de Gouveia L, et al. Declining incidence of invasive meningococcal disease in South Africa: 2003-2016. Clin Infect Dis 2018 (published online Oct 23)

Mentzer D, Oberle D, Keller-Stanislawski B. Adverse events following immunisation with a meningococcal serogroup B vaccine: report from post-marketing surveillance, Germany, 2013 to 2016. Euro Surveill 2018 Apr 26;23(17):pii=17-00468

Miglietta A, Fazio C, Neri A, et al. Interconnected clusters of invasive meningococcal disease due to Neisseria meningitides serogroup C ST-11 (cc11), involving bisexuals and men who have sex with men, with discos and gay-venues hotspots of transmission, Tuscany, Italy, 2015 to 2016. Euro Surveill 2018 Aug 23;23(34):pii=1700636

Miglietta A, Innocenti F, Pezzotti P, et al. Carriage rates and risk factors during an outbreak of invasive meningococcal disease due to Neisseria meningitides serogroup C ST-11 (cc11) in Tuscany, Italy: a cross-sectional study. BMC Infect Dis 2019 Jan 8;19:29

Moore AE, MacNeil JR, Wang X, et al. Emergence of localized serogroup W meningococcal disease in the United States — Georgia, 2006-2016. MMWR 2018 Aug 17;67(32):894-7

Mukaigawara M, Nakayama I, Gibo K. Strongyloidiasis and culture-negative suppurative meningitis, Japan, 1993-2015. Emerg Infect Dis 2018 (published online Oct 30)

Okike IO, Ladhani SN, Johnson AP, et al. Clinical characteristics and risk factors for poor outcome in infants less than 90 days of age with bacterial meningitis in the United Kingdom and Ireland. Pediatr Infect Dis J 2018 Sep;37(9):837-43

Oordt-Speets AM, Bolijn R, van Hoorn RC, et al. Global etiology of bacterial meningitis: a systematic review and meta-analysis. PLoS One 2018 Jun 11;13(6):e0198772

Ouldali N, Levy C, Varon E, et al. Incidence of paediatric pneumococcal meningitis and emergence of new serotypes: a time-series analysis of a 16-year French national survey. Lancet Infect Dis 2018 (published online Jul 23)

Parra MM, Gentile A, Narvaez JAV, et al. Immunogenicity and safety of the 4CMenB and MenACWY-CRM meningococcal vaccines administered concomitantly in infants: a phase 3b, randomized controlled trial. Vaccine 2018 (published online Nov 7)

Peterson ME, Mile R, Li Y, et al. Meningococcal carriage in high-risk settings: a systematic review. Int J Infect Dis 2018 (published online Jul 8)

Polkowska A, Skoczynska A, Paradowska-Stankiewicz I, et al. Pneumococcal meningitis before the introduction of 10-valent pneumococcal conjugate vaccine into the National Childhood Immunization Program in Poland. Vaccine 2019 (published online Jan 9)

Presa JV, de Almeida RS, Spinardi JR, et al. Epidemiological burden of meningococcal disease in Brazil: a systematic literature review and database analysis. Int J Infect Dis 2019 (published online Jan 11)

Rampakakis E, Vaillancourt J, Mursleen S, et al. Healthcare resource utilization and cost of invasive meningococcal disease in Ontario, Canada. Pediatr Infect Dis J 2019 Mar;38(3):253-7

Rees CA, Cruz AT, Freedman SB, et al. Application of the bacterial meningitis score for infants aged 0 to 60 days. J Pediatric Infect Dis Soc 2018 (published online Dec 10)

Regev-Yochay G, Reisenberg K, Katzir M, et al. Pneumococcal meningitis in adults after introduction of PCV7 and PCV13, Israel, July 2009-June 2015. Emerg Infect Dis 2018 (published online May 30)

Regev-Yochay G, Reisenberg K, Katzir M, et al. Pneumococcal meningitis in adults after introduction of PCV7 and PCV13, Israel, July 2009-June 2015. Emerg Infect Dis 2018 (published online May 30)

Rivera L, Chanthavanich P, Poder A, et al. MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: results from a phase III randomized trial. Vaccine 2018 (published online May 19)

Rogers T, Sok K, Erickson T, et al. Impact of antibiotic therapy in the microbiological yield of healthcare-associated ventriculitis and meningitis. Open Forum Infect Dis 2019 (published online Feb 6)

Smuts H, Cronje S, Thomas J, et al. Molecular characterization of an outbreak of enterovirus-associated meningitis in Mossel Bay, South Africa, December 2015-January 2016. BMC Infect Dis 2018 Dec 29;18:709

Soeters HM, McNamara LA, Blain AE, et al. University-based outbreaks of meningococcal disease caused by serogroup B, United States, 2013-2018. Emerg Infect Dis 2019 (published online Feb 13)

Thabuis A, Tararbit K, Taha MK, et al. Community outbreak of serogroup B invasive meningococcal disease in Beaujolais, France, February to June 2016: from alert to targeted vaccination. Euro Surveill 2018 Jul 12;23(28):pii=1700590

Vesikari T, Ostergaard L, Beeslaar J, et al. Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: a phase 3 extension study in adolescents. Vaccine 2019 (published online Feb 12)

White M, Idoko O, Sow S, et al. Antibody kinetics following vaccination with MenAfriVac: an analysis of serological data from randomised trials. Lancet Infect Dis 2019 (published online Feb 8)

Yaro S, Lafourcade BMN, Ouangraoua S, et al. Antibody persistence at the population level 56 years after mass vaccination with meningococcal serogroup A conjugate vaccine (PsA-TT) in Burkina Faso: need for a booster campaign? Clin Infect Dis 2018 (published online Jul 26)

Zunt JR, Kassebaum NJ, Blake N, et al. Global, regional, and national burden of meningitis, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018 Dec 1;17(12):1061-82

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead Become an underwriter»